Location: Boston, MA
CIK: 0001583977 · Show all filings
Period: Q3 2024 (← Previous) (Next →)
Filing Date: Nov 14, 2024
Total Value: $1.886B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 8,494,151 | $428M | 22.7% | $12.22 | +283.4% | CLASS A ORD | 61559X104 |
| PCVX | VAXCYTE INC | 1,000,000 | $114M | 6.1% | $53.56 | +68.3% | COM | 92243G108 |
| ACLX | ARCELLX INC | 1,250,000 | $104M | 5.5% | $23.33 | +185.5% | COMMON STOCK | 03940C100 |
| — | LONGBOARD PHARMACEUTICALS IN | 2,790,462 | $93.01M | 4.9% | $16.70 | — | COM | 54300N103 |
| EWTX | EDGEWISE THERAPEUTICS INC | 3,406,534 | $90.92M | 4.8% | $23.63 | -15.8% | COM | 28036F105 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 8,325,000 | $66.52M | 3.5% | $11.03 | -20.4% | COM NEW | 30233G209 |
| RAPP | RAPPORT THERAPEUTICS INC | 2,940,921 | $60.23M | 3.2% | $23.15 | -7.2% | COM | 75383L102 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 1,100,000 | $56.21M | 3.0% | $24.75 | +108.3% | COM | 22663K107 |
| PRAX | PRAXIS PRECISION MEDICINES I | 870,000 | $50.06M | 2.7% | $36.59 | +47.6% | COM NEW | 74006W207 |
| CRBP | CORBUS PHARMACEUTICALS HLDGS | 2,375,000 | $49M | 2.6% | $28.57 | +79.1% | COM NEW | 21833P301 |
| RNAM | AVIDITY BIOSCIENCES INC | 1,050,000 | $48.23M | 2.6% | $37.44 | +15.9% | COM | 05370A108 |
| JANX | JANUX THERAPEUTICS INC | 1,050,000 | $47.7M | 2.5% | $28.97 | +50.2% | COM | 47103J105 |
| BBIO | BRIDGEBIO PHARMA INC | 1,858,351 | $47.31M | 2.5% | $17.77 | +47.7% | COM | 10806X102 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 2,470,000 | $41M | 2.2% | $20.01 | -13.6% | ORDINARY SHARES | N62509109 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 2,561,600 | $40.96M | 2.2% | $13.13 | — | SPONSORED ADS | 152309100 |
| — | MERUS N V | 740,000 | $36.97M | 2.0% | $47.13 | — | COM | N5749R100 |
| CGON | CG ONCOLOGY INC | 975,000 | $36.79M | 2.0% | $39.73 | -11.8% | COM | 156944100 |
| INSM | INSMED INC | 500,000 | $36.5M | 1.9% | $25.23 | +192.5% | COM PAR $.01 | 457669307 |
| BMEA | BIOMEA FUSION INC | 3,570,872 | $36.07M | 1.9% | $17.07 | -61.9% | COM | 09077A106 |
| AXSM | AXSOME THERAPEUTICS INC | 400,000 | $35.95M | 1.9% | $74.04 | +17.9% | COM | 05464T104 |
| BIOA | BIOAGE LABS INC | 1,629,529 | $33.89M | 1.8% | $20.04 | 0.0% | COM | 09077V100 |
| BBOT | HELIX ACQUISITION CORP II | 2,909,000 | $30.4M | 1.6% | $10.35 | +0.1% | CL A ORD SHS | G4444H101 |
| PHVS | PHARVARIS N V | 1,466,460 | $27.16M | 1.4% | $21.48 | -14.9% | COM | N69605108 |
| ABVX | ABIVAX SA | 2,130,000 | $24.54M | 1.3% | $10.70 | — | SPONSORED ADS | 00370M103 |
| ALMS | ALUMIS INC | 2,147,396 | $22.93M | 1.2% | $13.30 | -8.8% | COM | 022307102 |
| — | CARGO THERAPEUTICS INC | 1,182,563 | $21.82M | 1.2% | $23.15 | — | COM | 14179K101 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 2,325,000 | $21.62M | 1.1% | $7.71 | +27.9% | COM | 03969K108 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 400,000 | $20.96M | 1.1% | $19.33 | +147.9% | COM | 76243J105 |
| BHVN | BIOHAVEN LTD | 401,963 | $20.09M | 1.1% | $43.60 | -10.8% | COM | G1110E107 |
| URGN | UROGEN PHARMA LTD | 1,550,000 | $19.68M | 1.0% | $14.22 | +4.4% | COM | M96088105 |
| — | Y-MABS THERAPEUTICS INC | 1,450,000 | $19.07M | 1.0% | $12.08 | — | COM | 984241109 |
| MBX | MBX BIOSCIENCES INC | 700,000 | $18.19M | 1.0% | $22.87 | 0.0% | COM | 55287L101 |
| TARS | TARSUS PHARMACEUTICALS INC | 500,000 | $16.45M | 0.9% | $21.36 | +31.6% | COM | 87650L103 |
| AVBP | ARRIVENT BIOPHARMA INC | 585,462 | $13.76M | 0.7% | $20.47 | +10.9% | COM | 04272N102 |
| ANAB | ANAPTYSBIO INC | 342,465 | $11.47M | 0.6% | $34.16 | 0.0% | COM | 032724106 |
| KRRO | KORRO BIO INC | 265,826 | $8.884M | 0.5% | $32.95 | +27.7% | COM | 500946108 |
| SLN | SILENCE THERAPEUTICS PLC | 400,000 | $7.272M | 0.4% | $21.60 | — | ADS | 82686Q101 |
| ENGN | ENGENE HOLDINGS INC | 1,000,000 | $6.6M | 0.3% | $12.24 | -39.2% | COM | 29286M105 |
| STOK | STOKE THERAPEUTICS INC | 427,163 | $5.25M | 0.3% | $26.85 | -47.2% | COM | 86150R107 |
| NGNE | NEUROGENE INC | 107,344 | $4.504M | 0.2% | $14.32 | +170.8% | COM | 64135M105 |
| GHRS | GH RESEARCH PLC | 593,043 | $3.967M | 0.2% | $20.43 | -49.8% | ORDINARY SHARES | G3855L106 |
| VYNE | VYNE THERAPEUTICS INC | 1,394,336 | $2.621M | 0.1% | $3.12 | -39.2% | COM | 92941V308 |
| — | VERVE THERAPEUTICS INC | 350,000 | $1.694M | 0.1% | $49.89 | — | COM | 92539P101 |
| ARTV | ARTIVA BIOTHERAPEUTICS INC | 103,633 | $1.601M | 0.1% | $11.59 | 0.0% | COM | 04317A107 |
| — | RAPT THERAPEUTICS INC | 496,750 | $998K | 0.1% | $20.60 | — | COM | 75382E109 |